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Abstract
Infective endocarditis (IE) is becoming a more common illness in children, especially in patients with congenital heart 
disease. There remains no consensus as to the optimal diagnosis, treatment and prophylaxis. One of the most chal-
lenging problems in this group of patients is surgery, because of the often extremely small dimensions and the lack of 
proper valve prosthesis. In light of this growing problem, there is a need for better knowledge regarding IE if this insidious 
disease is to to be promptly identified and and effectively treated.
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Introduction
Over the last few decades, the epidemiology of infective 
endocarditis (IE) in the paediatric population has changed. 
In the 1970s roughly 30–50% of cases of IE in children 
were related to rheumatic heart disease [1], whereas 
nowadays congenital heart disease (CHD) is the most 
common reason for IE. Moreover, the increased frequen-
cy of IE is strongly connected with the increased survival 
rate among patients with CHD. The incidence of IE has 
been estimated to be approximately 0.05–0.12 cases per 
1,000 paediatric admissions by different centres [2–5], 
while the figure reported from the USA is 0.43 cases per 
100,000 children [3]. The increasing prevalence of IE in the 
paediatric population is associated with general immune 
deficiency, invasive devices, and innovative surgical proce-
dures designed for complex cyanotic CHD, especially those 
associated with artificial material implantation, as well as 
the complexity of comprehensive treatment in intensive 
care units. Nevertheless, 8–10% of cases of IE in children 
are not associated with CHD or any evident risk factor [6]. 
In such cases, IE usually affects the aortic or mitral valves 
and comes from Staphylococcus aureus bacteraemia [7].
Although the incidence of IE in children is lower than in 
adults, it is more difficult to treat. The lack of clear guide-
lines for the treatment of endocarditis in children makes 
it an even more complicated and problematic challenge.
Cardiac surgery  
and transcatheter procedures
Cardiac surgery and postoperative intensive care is an im-
portant independent risk factor for the development of IE. In 
particular, residual defects and surgical shunts contribute 
to damage of the endocardium and infiltration by bacteria. 
Those most susceptible to IE are cyanotic children after 
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they have undergone corrective, palliative or physiological 
palliation surgery for CHD [8].
Although always possible, the risk of endocarditis in the 
first month after cardiac surgery is low. The risk usually rises 
as time goes by. IE can be a late complication of cardiac 
surgery for CHD, but unfortunately such a late occurrence 
is connected with rapid development and poor antibiotic 
response [9, 10].
Patients after transcatheter device implantation are 
also at risk of endocarditis, especially before the endothe-
lialisation of the implants. The residual defects could be 
an additional risk factor for IE [11–13].
Pathogenesis
The interaction of two factors is necessary for IE to develop 
— endothelium damage and bacteraemia [14]. Turbulent 
flow (i.e. valvular disease, stenosis or regurgitation, residual 
shunt, recurrent stenosis) causes mechanical stress, which 
destroys the endothelium, followed by the deposition of 
platelets and fibrin, and finally the creation of nonbacterial 
thrombotic endocarditis (NBTE). NBTE is a perfect nidus for 
bacterial or fungal colonisation. Bacteraemia or fungemia 
can appear in the blood from any infection site, and even 
as a result of everyday activities such as brushing teeth 
or chewing food. The pathogens after nidus colonisation 
and multiplication cause a further adhesion of platelets 
and fibrin. In chronic cardiac patients, the endothelium 
surface is frequently damaged by catheters or pacing wires; 
endocarditis can also develop due to direct infection from 
implantable devices.
Diagnosis
Infective endocarditis is a difficult diagnostic problem, 
mostly because of its non-specific clinical symptoms. 
Clinical findings differ between neonates, children and 
adolescents. Infants with IE usually present feeding dif-
ficulties, tachycardia, respiratory disorders, hypotension, 
and a variety of neurological signs such as seizures, 
hemiparesis or apnoea. During physical examination, 
a new or changing heart murmur can be heard. However, 
in older children and adolescents, IE is associated with 
prolonged low-grade fever, fatigue, weight loss, weakness, 
arthralgias, myalgias and diaphoresis. In some cases, the 
symptoms of IE can develop rapidly with a high fever and 
progressive heart failure. These patients usually require 
urgent intervention, and the most likely aetiological factors 
are usually Streptococcus pneumoniae or Staphylococcus 
aureus [8, 10].
Due to its nonspecific clinical findings, endocarditis sho-
uld be taken into consideration in every case of prolonged, 
nonresponding to antibiotics infection with fever, especially 
in children with congenital heart disease, and also in long 
term follow-up after corrective surgery. Extracardiac fin-
dings such as petechiae, haemorrhages, Janeway lesions, 
Roth’s spots or Osler nodes, are uncommon in children. The 
emboli of vessels in the abdominal viscera, in the heart, or 
in the brain, although rare, can be life threatening.
In clinical practice, a diagnosis of IE depends on 
proving a relationship between the signs of infection and 
echocardiographic changes on the endocardium. Both the 
European Society of Cardiology (ESC) and the American 
Heart Association (AHA) recommend using the Duke criteria 
for diagnosing IE in adults [15].
Modifications of the Duke criteria for children have been 
used in several studies, but because of the small number of 
patients, there remain doubts about their universal appli-
cability [16, 17]. The Duke criteria are based on clinical, 
microbiological and echocardiographic findings (Table 1). 
The original Duke criteria have only 80% sensitivity in epi-
demiologic studies and less than 65% (63.2%) in clinical 
practice [18]. To improve the accuracy of diagnosis in 
adults, it is recommended to consider new imaging techni-
ques such as multi-slice computer tomography (MSCT) and 
single-photon emission computed tomography/computed 
tomography (SPECT/CT) [19, 20]. These techniques have 
thus far no applications or certification in the paediatric 
population.
The gold standard of IE diagnosis is microbiological 
and histological examination of surgically excised tissue 
specimens such as valves, a damaged endocardium, or 
vegetations.
Imaging
The most important imaging techniques in IE are transtho-
racic (TTE) and transoesophageal (TEE) echocardiography. 
Echocardiographic examination should be performed in 
every patient with a suspicion of IE [14]. It has an important 
role in diagnosis, evaluation of treatment, and monitoring of 
recurrence. In children, TTE is usually sufficient to visualise 
changes in the endocardium and dysfunction of the valves. 
TEE could be helpful in the evaluation of paravalvular leaka-
ge, left ventricle outflow tract complication, root abscesses, 
or endocarditis over a prosthetic valve (Figure 1). Those 
patients with chest deformations after surgery, trauma or 
congenital lesions, can also be better assessed with TEE.
Microbiology
Identifying the pathogen responsible for IE is very impor-
tant, so it is crucial to take blood samples for microbiolo-
gical examination as quickly as possible in every patient 
suspected of IE, especially where there is fever of an 
unexplained origin (FUO), a new heart murmur, a congenital 
diaphragmatic hernia (CDH), or a previous history of endo-
carditis. The process involves taking three blood cultures 
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Table 1. Modified Duke criteria for diagnosis of infective endocarditis in children (based on [15])
Major criteria
1. Positive blood culture for IE:
a) typical microorganism consistent with IE from ≥ 2 blood cultures:
•	 Viridans streptococci, Streptococcus bovis, or HACEK group; or
• community-acquired Staphylococcus aureus or enterococci, in the absence of a primary focus; or
b) microorganisms consistent with IE from persistently positive blood cultures, defined as:
• ≥ 2 positive cultures of blood samples drawn > 12 h apart; or
• all of three or a majority of ≥ 4 blood cultures, irrespective of the timing
c) 1 positive blood culture for Coxiella burnetii or antiphase-I immunoglobulin G antibody titre > 1:800
2. Evidence of endocardial involvement:
a) echocardiogram positive for IE (TEE recommended in prosthetic valves, rated at least possible IE by clinical criteria,  
  or complicated IE; TTE as the first test in other patients) for IE, defined as:
• oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the 
absence of an alternative anatomic explanation; or
• abscess; or
• new partial dehiscence of prosthetic valve
b) new valvular regurgitation (worsening or changing of pre-existing murmur not sufficient)
Minor criteria
1. Predisposition: predisposing heart condition or IV drug use
2. Fever: temperature ≥ 38.0°C
3. Vascular phenomena: major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial haemorrhage, conjunctival 
haemorrhages, and Janeway lesions
4. Immunologic phenomena: glomerulonephritis, Osler nodes, Roth’s spots, and rheumatoid factor
5. Microbiological evidence: positive blood culture but does not meet a major criterion as noted above or serological evidence of acti-
ve infection with organism consistent with IE
Figure 1. Transoesophageal echocardiography (TEE) in a 9 year-old boy with infective endocarditis caused by Cardiobacterium hominis. 
Periannular abscess (arrow) and vegetations attached to leaflets of aortic valve
A B
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by separate venous punctures on the first day of fever; if 
there is no growth after two days of incubation, another 
2–3 blood samples should be taken.
Because of the relatively lower volume of circulating 
blood in children, the blood samples have to be smaller. 
In infants and younger children they should be limited to 
1–3 mL, and 5–7 mL in older children. Bacteraemia is 
usually constant in IE, so there is no need to wait for py-
rexia. Isolated growth in one sample should be taken into 
consideration with great care, due to the high possibility 
of contamination [15].
Most cases of IE are caused by the ‘big three’ patho-
gens — viridans group streptococci (VGS, like Streptococcus 
sanquis, Streptococcus mitis group, Streptococcus mu-
tans), staphylococci (Staphylococcus aureus, coagulase-
-negative staphylococci), β-haemolytic streptococci and 
Enterococcus species (less common in children). Less 
common aetiological pathogens are microorganisms from 
the HACEK (Haemophilus species, Aggregatibacter species, 
Cardiobacterium hominis, Eikenella corrodens and Kingella 
species) group.
If fastidious organisms or unusual pathogens are 
suspected, the microbiological laboratory should be fo-
rewarned so that it can use longer incubation and more 
specific tests. From the age of 12 months onwards, the 
most common endocarditis pathogen in children with 
CHD is VGS. However, after cardiac surgery S. aureus and 
coagulase-negative staphylococci are more common [1, 6].
Culture-negative endocarditis
Up to 36% of patients with diagnosed endocarditis 
have negative blood cultures [21]. The reason behind 
a culture-negative endocarditis (CNE)-diagnosis is anti-
biotic therapy introduction before the collection of blood 
samples, or the need to make maximum efforts to search 
for organisms, which require more demanding conditions. 
Because of the nonspecific, slowly developing signs, 
the majority of patients are treated with antibiotics by 
a paediatrician or a general practitioner prior to IE being 
suspected.
Fastidious microorganisms, some bacteria and fungi, 
require more specific media and longer incubation times. 
Except for extended incubation, in some cases it is worth 
performing serological tests or using molecular techniques 
such as polymerase chain reaction (PCR) to detect RNA/DNA 
of the microorganisms [22].
The tests over surgically excised tissue can help to de-
termine the aetiological factor behind IE, but they should 
be interpreted cautiously, because 13–55% of results are 
false-positive. Surgical materials remain positive for months 
after antibiotic therapy has begun, but unfortunately can 
detect microorganisms from previous episodes of endocar-
ditis up to 12 years before surgery [22, 23].
Treatment
The treatment of IE consists of two complementary parts — 
antibiotic therapy and surgery. The immediate implementa-
tion of appropriate antibiotic therapy is extremely important 
for a successful outcome. Antibiotic therapy depends on 
having a diagnosed or suspected aetiological factor. There 
are different antibiotic strategies and durations of therapy, 
which usually lasts a minimum of 6–8 weeks. There are 
also therapeutic strategies for CNE, which should be re-
-evaluated as soon as a more precise diagnosis is made, 
i.e. after histological tests. Preoperative antibiotics therapy 
should be taken into account for the total duration of the-
rapy, unless there is a need to change antibiotics based on 
blood cultures. Although there has been an improvement 
in IE treatment, the mortality rate is still 5–10% [15], and 
is higher in patients with previous heart disease.
Surgical treatment
The two major goals of surgical treatment of IE are to exci-
se the infected tissues, and to restore the correct cardiac 
function.
The vegetations can cause valvular dysfunction, perian-
nular progression of infection, sinus of Valsalva rupture, 
myocardial dysfunction, obstruction of conduits and shunts, 
pericardial effusion, coronary embolisation or dysfunction 
of artificial valves. Surgery is usually urgently required, 
especially in life-threatening conditions [24]. The most 
important indications for surgery are the progression of 
heart failure, uncontrolled infection, and emboli prevention.
Cardiac surgery for IE in children is an enormous 
challenge which grows more demanding the smaller the 
patient is. The first surgical challenge relates to the size 
of the patient. Even a fairly small vegetation on the valve 
or a periannular abscess can lead to resection of large 
cardiac structures or whole cusps of infected valve. The 
second basic problem of paediatric IE is the lack of pro-
per valve prosthesis and materials to reconstruct cardiac 
morphology. There is no ‘paediatric’ size of artificial valve, 
either mechanical or biological. In addition, it should be 
remembered that no prosthetic valve has growth potential 
and a small prosthesis will have to be changed as the child 
grows. However, there have been promising initial reports 
on the use of a biological valve placed on a stent (Melody® 
valve; Figure 2) that could be percutaneously widened with 
balloons in the future [25].
It is vital to clear all current and suspected extracardiac 
sites of infection before cardiac surgery.
Prevention
Both the AHA and the ESC limit the use of antibiotic pro-
phylaxis to patients with the highest risk for IE and patients 
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with the highest risk for mortality or morbidity from IE. This 
is a consequence of the data that shows that up to 20% of 
IE could be associated with invasive procedures. Transient 
bacteraemia appears during everyday activities such as 
brushing teeth or chewing food. The oral flora in children 
and adults differs, and changes with age. Nonetheless, 
dental hygiene and careful treatment of any oral infection 
should be undertaken [26].
The other issue is for a patient with CHD, particularly 
cyanotic heart disease. The presence of implanted foreign 
prosthetic materials such as patches, shunts or conduits, 
increases the risk of endocarditis, even many years after 
cardiac surgery. The AHA recommends antibiotic prophyla-
xis before high-risk dental procedures for all patients with 
unrepaired cyanotic CHD, as well as those individuals who 
underwent the repair of a CHD with prosthetic materials, or 
with diagnosed residual defects, and after percutaneous 
device implantation (for a period of six months). Particular 
attention should be paid to oral hygiene in children with 
cyanosis, who have specific periodontal concerns [27].
Conclusions
1. The growing number of children and adolescents with 
corrected CHD is the cause of the growing risk of IE. The-
refore this particular group of patients should be treated 
by highly specialised teams familiar with congenital heart 
surgery. 2. There is a need for better knowledge about IE in 
children among general practitioners and paediatricians, as 
well as dentists, to provide a proper prophylaxis and shor-
ten the time to diagnosis, introduce effective treatment, 
and improve outcomes. 3. The growing number of children 
suffering from IE should encourage progress in the field 
of prosthetic implantable materials that could minimise 
the risk of IE, while considering the potential to expand 
following children’s growth.
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Figure 2A, B. Melody valve® in mitral position in a 3 year-old girl — 
12 months after implantation because of acute mitral insufficiency 
in the course of infective endocarditis. There is possibility to per-
cutaneous widen the diameter of the valve calibrated foramen in 
interatrial septum
Streszczenie
Zachorowalność na infekcyjne zapalenie wsierdzia (IE) wzrasta w populacji dziecięcej, zwłaszcza u pacjentów z wrodzoną 
wadą serca. Właściwe postępowanie, diagnostyka, leczenie oraz właściwa profilaktyka pozostają przedmiotem wielu 
dyskusji. Leczenie chirurgiczne IE u dzieci stanowi szczególne wyzwanie, głównie z powodu małych rozmiarów pacjenta, 
konieczności zachowania potencjału do wzrostu i braku odpowiednich protez zastawkowych. W obliczu narastającego 
problemu należy zwiększać świadomość i propagować wiedzę o IE, żeby wcześnie rozpoznawać i skutecznie leczyć tę 
podstępną chorobę na wcześniejszych etapach.
Słowa kluczowe: infekcyjne zapalenie wsierdzia, kardiochirurgia dziecięca, zastawki, dzieci
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